Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: OLINK PROTEOMICS INC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-09-04 to 2025-09-29
Current total value of award: $99413
Description: CARDIOTOXICITY BIOMARKER ANALYSIS FOR PLASMA SAMPLES FROM CANCER PATIENTS